An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.
Investigational Drug Acquiring Traction Via Social Media
Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these profiles privately for source information, while also receiving discount codes.
Active Commerce on Social Networks
Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison images, administration instructions and claims of rapid British shipping. Sellers promote the drug there before directing buyers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Experts Express Worries
However, physicians and chemists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to users administering substances of unknown origin.
Several experts stated the demand for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.
Some influencers try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still violate medicines, advertising, and consumer regulations, risking fines, prosecution or prison.
Platform Response and Material Removal
According to TikTok, the platform has removed problematic content and prohibited associated hashtags and search suggestions. The company stated it was dedicated to maintaining the service safe and allocating resources in strengthening enforcement strategies.
Online Trading Activities
Research also found communities with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, populated with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at home.
Within moments of entering one group, a vendor posted contact information, where the majority of transactions occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about weight, medical conditions or past usage.
Item Information and Costs
Within these groups, posts display black plastic packages with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20mg. When asked how much time a injector should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.
Platform Moderation and Safety Measures
A representative for the messaging service said it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is valid, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.
Her staff has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose users to potentially serious medical dangers”.
